SHELDON KAPLAN to Gram-Positive Bacterial Infections
This is a "connection" page, showing publications SHELDON KAPLAN has written about Gram-Positive Bacterial Infections.
Connection Strength
1.007
-
Challenges in the evaluation and management of bone and joint infections and the role of new antibiotics for gram positive infections. Adv Exp Med Biol. 2009; 634:111-20.
Score: 0.298
-
Use of linezolid in children. Introduction. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S151-2.
Score: 0.206
-
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J. 2003 Aug; 22(8):677-86.
Score: 0.205
-
The prevalence of antiseptic tolerance genes among staphylococci and enterococci in a pediatric population. Infect Control Hosp Epidemiol. 2019 03; 40(3):333-340.
Score: 0.151
-
The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin. J Antimicrob Chemother. 2010 Oct; 65(10):2267-70.
Score: 0.083
-
Linezolid for the treatment of complicated skin and skin structure infections in children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S172-7.
Score: 0.051
-
Hematologic effects of linezolid in young children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S186-92.
Score: 0.013